BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 16677655)

  • 1. Inhibition of injury-induced arterial remodelling and carotid atherosclerosis by recombinant human antibodies against aldehyde-modified apoB-100.
    Ström A; Fredrikson GN; Schiopu A; Ljungcrantz I; Söderberg I; Jansson B; Carlsson R; Hultgårdh-Nilsson A; Nilsson J
    Atherosclerosis; 2007 Feb; 190(2):298-305. PubMed ID: 16677655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the target for therapeutic recombinant anti-apoB-100 peptide antibodies in human atherosclerotic lesions.
    Gonçalves I; Nitulescu M; Ares MP; Fredrikson GN; Jansson B; Li ZC; Nilsson J
    Atherosclerosis; 2009 Jul; 205(1):96-100. PubMed ID: 19150065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant antibodies to an oxidized low-density lipoprotein epitope induce rapid regression of atherosclerosis in apobec-1(-/-)/low-density lipoprotein receptor(-/-) mice.
    Schiopu A; Frendéus B; Jansson B; Söderberg I; Ljungcrantz I; Araya Z; Shah PK; Carlsson R; Nilsson J; Fredrikson GN
    J Am Coll Cardiol; 2007 Dec; 50(24):2313-8. PubMed ID: 18068040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis.
    Schiopu A; Bengtsson J; Söderberg I; Janciauskiene S; Lindgren S; Ares MP; Shah PK; Carlsson R; Nilsson J; Fredrikson GN
    Circulation; 2004 Oct; 110(14):2047-52. PubMed ID: 15451805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of T helper 2 responses against human apolipoprotein B100 does not affect atherosclerosis in ApoE-/- mice.
    Engelbertsen D; Rattik S; Knutsson A; Björkbacka H; Bengtsson E; Nilsson J
    Cardiovasc Res; 2014 Jul; 103(2):304-12. PubMed ID: 24866382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune responses against the apo B-100 LDL receptor-binding site protect against arterial accumulation of lipids in LDL receptor deficient mice.
    Fredrikson GN; Lindholm MW; Ljungcrantz I; Söderberg I; Shah PK; Nilsson J
    Autoimmunity; 2007 Mar; 40(2):122-30. PubMed ID: 17453711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of immune responses against aldehyde-modified peptide sequences in apoB associated with cardiovascular disease.
    Fredrikson GN; Hedblad B; Berglund G; Alm R; Ares M; Cercek B; Chyu KY; Shah PK; Nilsson J
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):872-8. PubMed ID: 12649091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral immune response against defined oxidized low-density lipoprotein antigens reflects structure and disease activity of carotid plaques.
    Gonçalves I; Gronholdt ML; Söderberg I; Ares MP; Nordestgaard BG; Bentzon JF; Fredrikson GN; Nilsson J
    Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1250-5. PubMed ID: 15831809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with apo B peptide vaccines inhibits atherosclerosis in human apo B-100 transgenic mice without inducing an increase in peptide-specific antibodies.
    Fredrikson GN; Björkbacka H; Söderberg I; Ljungcrantz I; Nilsson J
    J Intern Med; 2008 Dec; 264(6):563-70. PubMed ID: 18783480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization with a combination of ApoB and HSP60 epitopes significantly reduces early atherosclerotic lesion in Apobtm2SgyLdlrtm1Her/J mice.
    Lu X; Chen D; Endresz V; Xia M; Faludi I; Burian K; Szabo A; Csanadi A; Miczak A; Gonczol E; Kakkar V
    Atherosclerosis; 2010 Oct; 212(2):472-80. PubMed ID: 20609438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune responses against aldehyde-modified laminin accelerate atherosclerosis in Apoe-/- mice.
    Dunér P; To F; Berg K; Alm R; Björkbacka H; Engelbertsen D; Fredrikson GN; Nilsson J; Bengtsson E
    Atherosclerosis; 2010 Oct; 212(2):457-65. PubMed ID: 20810111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences.
    Fredrikson GN; Söderberg I; Lindholm M; Dimayuga P; Chyu KY; Shah PK; Nilsson J
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):879-84. PubMed ID: 12649092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating autoantibodies against the apolipoprotein B-100 peptides p45 and p210 in relation to the occurrence of carotid plaques in 64-year-old women.
    Fagerberg B; Prahl Gullberg U; Alm R; Nilsson J; Fredrikson GN
    PLoS One; 2015; 10(3):e0120744. PubMed ID: 25768285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced connexin43 expression limits neointima formation after balloon distension injury in hypercholesterolemic mice.
    Chadjichristos CE; Matter CM; Roth I; Sutter E; Pelli G; Lüscher TF; Chanson M; Kwak BR
    Circulation; 2006 Jun; 113(24):2835-43. PubMed ID: 16769907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination against T-cell epitopes of native ApoB100 reduces vascular inflammation and disease in a humanized mouse model of atherosclerosis.
    Gisterå A; Hermansson A; Strodthoff D; Klement ML; Hedin U; Fredrikson GN; Nilsson J; Hansson GK; Ketelhuth DF
    J Intern Med; 2017 Apr; 281(4):383-397. PubMed ID: 28194913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of multiple antigenic epitopes from ApoB100, hHSP60 and Chlamydophila pneumoniae on atherosclerotic lesion development in Apob(tm2Sgy)Ldlr(tm1Her)J mice.
    Lu X; Xia M; Endresz V; Faludi I; Szabo A; Gonczol E; Mundkur L; Chen D; Kakkar V
    Atherosclerosis; 2012 Nov; 225(1):56-68. PubMed ID: 22959702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization with cationized BSA inhibits progression of disease in ApoBec-1/LDL receptor deficient mice with manifest atherosclerosis.
    Kolbus D; Wigren M; Ljungcrantz I; Söderberg I; Alm R; Björkbacka H; Nilsson J; Fredrikson GN
    Immunobiology; 2011 Jun; 216(6):663-9. PubMed ID: 21247654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crucial role of stromal cell-derived factor-1alpha in neointima formation after vascular injury in apolipoprotein E-deficient mice.
    Schober A; Knarren S; Lietz M; Lin EA; Weber C
    Circulation; 2003 Nov; 108(20):2491-7. PubMed ID: 14581398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein B binding domains: evidence that they are cell-penetrating peptides that efficiently deliver antigenic peptide for cross-presentation of cytotoxic T cells.
    Sakamoto N; Rosenberg AS
    J Immunol; 2011 Apr; 186(8):5004-11. PubMed ID: 21402897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The vascular repair process after injury of the carotid artery is regulated by IL-1RI and MyD88 signalling.
    Saxena A; Rauch U; Berg KE; Andersson L; Hollender L; Carlsson AM; Gomez MF; Hultgårdh-Nilsson A; Nilsson J; Björkbacka H
    Cardiovasc Res; 2011 Jul; 91(2):350-7. PubMed ID: 21421554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.